. . . . . . . . . . . . . . "cat(p(MGI:Sptlc2)) -> a(CHEBI:ceramide)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . " Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased plasma ceramide (45% and 39%, P<0.01, respectively), sphingosine-1-phosphate (31% and 32%, P<0.01, respectively) and sphingosine levels (22.5% and 25%, P<0.01, respectively); (6) dramatically decreased plasma lysosphingomyelin (17-fold and 16-fold, P<0.0001, respectively); and " . . "Selventa" . . . . "2014-07-03T14:32:51.229+02:00"^^ . . .